Compare INDV & CVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | CVSA |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | 4996 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.9B |
| IPO Year | 2014 | N/A |
| Metric | INDV | CVSA |
|---|---|---|
| Price | $31.49 | $112.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $150.00 |
| AVG Volume (30 Days) | ★ 2.3M | 260.2K |
| Earning Date | 06-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 1.64 | N/A |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | N/A | $9.66 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | $19.28 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $8.69 | $96.08 |
| 52 Week High | $38.00 | $118.80 |
| Indicator | INDV | CVSA |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 55.00 |
| Support Level | $29.71 | $112.05 |
| Resistance Level | $35.75 | $118.80 |
| Average True Range (ATR) | 1.20 | 3.60 |
| MACD | 0.30 | -0.60 |
| Stochastic Oscillator | 74.90 | 27.54 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.